论文部分内容阅读
目的:探讨亿活联合菌栀黄口服液对新生儿黄疸早期干预的临床疗效。方法:随机选择60例新生儿黄疸病例,将其随机分为实验组和对照组,每组30例。实验组采用早期亿活联合菌栀黄口服液干预+常规治疗;对照组采用常规治疗法。结果:实验组中,23例治愈,5例明显好转,2例无效,有效率为96.67%。对照组中,20例治愈,6例好转,4例无效,有效率为86.67%。实验组疗效明显优于对照组。结论:亿活联合菌栀黄口服液对新生儿黄疸进行早期干预的临床疗效显著,有很好的临床推广价值。
Objective: To investigate the clinical efficacy of Yixiu combined with Zhizhi Oral Liquid in the early intervention of neonatal jaundice. Methods: Sixty cases of neonatal jaundice were randomly selected and randomly divided into experimental group and control group, with 30 cases in each group. In the experimental group, the interventional treatment of early combined with Yi Zhi Zhi Huang oral liquid was adopted. In the control group, conventional treatment was used. Results: In the experimental group, 23 cases were cured, 5 cases improved obviously, 2 cases were ineffective, and the effective rate was 96.67%. In the control group, 20 cases were cured, 6 cases improved, 4 cases were ineffective, and the effective rate was 86.67%. Experimental group was significantly better than the control group. Conclusion: The clinical efficacy of YIUJI ZHIHUANG Oral Liquid in early intervention of neonatal jaundice is significant, and it has good clinical value.